Samsung Biologics Labor and Management Fail to Reach Agreement... Strike Continues Until May 5
One-on-One Negotiations Between Chief Representatives Scheduled for May 6
Tripartite Labor-Management-Government Meeting Set for May 8
On May 4, the fourth day of the full-scale strike at Samsung Biologics, labor and management sat down at the negotiating table but ultimately failed to reach an agreement. As a result, the union announced that it will continue with the planned full-scale strike until May 5 as originally scheduled.
The Samsung Biologics Win-Win Branch, part of the Samsung Group's super-enterprise labor union, and management held a labor-management-government meeting on the morning of May 4, mediated by the Central Regional Employment and Labor Office. The first round of talks began around 10:15 a.m. and lasted for about two hours, followed by individual meetings with the Ministry of Labor in the afternoon. However, both sides were unable to narrow their differences. Immediately after the first meeting, the union stated in an official statement that management had requested the suspension of all types of industrial action and the mutual withdrawal of all related disputes concerning unfair labor practices. However, the union made it clear that it rejected this request, judging that accepting it would only lower the level of industrial action without gaining any substantive concessions.
The afternoon meeting also ended without any specific agenda being presented or direction established. Although the two sides did not reach a concrete agreement that day, they agreed to continue ongoing communication. On May 6, a one-on-one meeting between the chief negotiators of both sides is scheduled, and on May 8, another tripartite meeting involving the Ministry of Labor will be held. In an official statement, management said, "Both labor and management participated in the talks in good faith, and we will actively take part in the two remaining sessions this week." The union also left the door open for further talks, stating, "This round of talks was not the final negotiation, but rather a process to confirm management's willingness to resolve the issue."
The main points of contention in the current labor dispute are the wage increase rate and the detailed provisions to be included in the collective agreement. The union is demanding a 14.3% increase in base salary along with an additional fixed increase of 3.5 million won. When calculated based on the starting salary for new hires, this fixed increment corresponds to approximately 7%, bringing the total wage increase rate to about 21.3%. The union's proposal also includes the payment of a 30 million won incentive bonus to each employee and allocating 20% of operating profit as performance bonuses.
In addition, the union has proposed codifying HR and key management decisions into the collective agreement. Specific demands include notification of appointments and changes in executive positions, mandatory provision of related documents upon the union's request, and joint participation of labor and management in management council decisions concerning performance distribution, recruitment, and personnel placement. The proposal also stipulates that matters such as company spin-offs, mergers, and outsourcing should be reviewed and approved by the Employment Stability Committee. Management maintains that these demands are of a scale and content that are difficult to accommodate in practice.
As the standoff continues, the impact of the strike on production is becoming increasingly evident. It is estimated that approximately 2,800 out of 4,000 union members have participated in this full-scale strike, which has been conducted by taking annual leave on weekdays and not working on weekends. Coupled with the effects of a partial strike involving about 60 workers from April 28 to 30, this has begun to affect product output. Management responded by deploying all available emergency personnel, but explained that it was nevertheless forced to halt production of a total of 23 batches, including anticancer drugs and HIV treatments. The company estimates that this production stoppage has resulted in losses of about 150 billion won.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The union announced that from May 6 it will return to the workplace but continue industrial action in the form of an indefinite, law-abiding struggle, refusing to work overtime or on holidays.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.